In keeping with its commitment to provide assured quality, the Unit I manufacturing facility at Bonthapally adheres to stringent guidelines and requirements of Good Manufacturing Practices (GMP) and is approved by international health and regulatory agencies such as US FDA, TGA (Australia), PMDA (Japan) and WHO.
A key feature of the manufacturing process is the supervision and the involvement of a committed team which with the help of latest production techniques and calibrated planning guarantees on-time delivery of products.
Unit I is situated at Bonthapally village in Medak District, which is approximately 65 kilometers from Hyderabad airport. It is developed on a total area of 11.2 acres and has seven production blocks including the kilo labs and other supporting departments such as Quality Assurance and Quality Control (QA & QC) and Regulatory Affairs (RA).
The facility has been inspected by the USFDA 6 times (1997, 2004, 2008, 2010, 2014, 2017) and by EDQM in 2005. The PMDA (Japan) audited and approved the facility in 2008. It is also certified by the following management systems:
The following is an illustrative list of reactions that are handled at Neuland’s facilities on a continuous basis:
It has come to our notice that fraudulent recruitment offers are being extended on behalf of Neuland Laboratories Ltd. in the name of Board of Directors by certain individuals/entities.